scholarly journals The Novel Coronavirus: A Bird's Eye View

Author(s):  
Parham Habibzadeh ◽  
Emily K. Stoneman

The novel coronavirus (2019-nCoV) outbreak, which initially began in China, has spread to many countries around the globe, with the number of confirmed cases increasing every day. With a death toll exceeding that of the SARS-CoV outbreak back in 2002 and 2003 in China, 2019-nCoV has led to a public health emergency of international concern, putting all health organizations on high alert. Herein, we present on an overview of the currently available information on the pathogenesis, epidemiology, clinical presentation, diagnosis, and treatment of this virus.

Author(s):  
Nusrat Mannan ◽  
Arifa Akram

In December 2019, the novel coronavirus (2019-nCoV) outbreak, began in China, which has now spread many countries around the globe in a form of pandemic, with the number of confirmed cases increasing every day. With a death toll exceeding that of the SARS-CoV outbreak, 2019-nCoV has led to a public health emergency of international concern, putting all health organizations around the world on a high alert. Here, we presented an overview of the currently available information on the clinical presentation and complication of this virus. Bangladesh Journal of Infectious Diseases, April 2020;7(suppl_1):S54-S57


2020 ◽  
Vol 0 (6) ◽  
pp. 7-32
Author(s):  
Duc Tien Nguyen ◽  
◽  
An Thanh T. Chu ◽  

The novel coronavirus has shaken the entire world to its roots. Yet, governments’ responses have taken many forms. Some countries were able to flatten the curve, while others struggled to pick up the pieces. This article provides governance implications drawn from Viet Nam’s COVID-19 experience. Accordingly, the country’s key features of its COVID-19 responses include resolute leadership, information transparency, central – local government coordination, public participation, and adequate preparedness. Besides, this article also highlights some of Viet Nam’s key legislative and policy initiatives in a bid to cautiously keep the pandemic under control and the economy rolling. By doing so, it makes a practical contribution to the discourse on public governance in the time of a public health emergency.


Author(s):  
Nikita Jatai ◽  
Tanu Sharma ◽  
Karan Veer

All over the world, there is a new target of public health emergency looming the world along with an appearance and distribution of the novel coronavirus disease (2019-nCoV) also known as Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). This Virus initially generated in bats and then after transferred to a human being over unknown animal playing the role of mediator in Wuhan, China in December 2019. This virus is passed by breathing or in contact with an infected person’s droplets. The Incubation period is between 2 to 14 days for COVID-19, that is the time between exposure of the virus (person becoming infected) and symptom on that person, is on an average of 5-6 days, however it can goes up to 14 days. Throughout this period, which can be also known as “pre-symptomatic” period, some of the infected patients or persons can be contagious. That is why, transferal from a pre-symptomatic case can happen before the symptoms onset. Where there is few number of case studies and reports, pre-symptomatic transferal has been documented via contact with someone who is diagnosed with virus and increase investigation of that particular clusters of total confirmed cases. The main problem is that the symptoms are just like the regular flu that are cough, fever, sore throat, fatigue and breathlessness. This virus is moderate or mild in most of the people, but in elder ones, it may proceed to pneumonia, multi-organ dysfunction and Acute Respiratory Distress Syndrome (ARDS). Coronavirus has significant consequences on the Health system, mainly on cardiovascular diseases and on the environment.


Author(s):  
Wai-Kit Ming ◽  
Jian Huang ◽  
Casper J. P. Zhang

AbstractA novel coronavirus pneumonia initially identified in Wuhan, China and provisionally named 2019-nCoV has surged in the public. In anticipation of substantial burdens on healthcare system following this human-to-human spread, we aim to scrutinise the currently available information and evaluate the burden of healthcare systems during this outbreak in Wuhan. We applied a modified SIR model to project the actual number of infected cases and the specific burdens on isolation wards and intensive care units, given the scenarios of different diagnosis rates as well as different public health intervention efficacy. Our estimates suggest the actual number of infected cases could be much higher than the reported, with estimated 26,701 cases (as of 28th January 2020) assuming 50% diagnosis rate if no public health interventions were implemented. The estimated burdens on healthcare system could be largely reduced if at least 70% efficacy of public health intervention is achieved.


2020 ◽  
Vol 54 (4s) ◽  
pp. 3-4
Author(s):  
George Amofah

The year 2020 has looked like a fairy tale as the COVID-19 pandemic swept across the world with devastating socio-economic and health consequences. The impact of the pandemic has depended, largely, on preparedness and response of countries, and their ability to adjust to the fast-evolving pandemic. The World Health Organization (WHO) declared the novel coronavirus outbreak a public health emergency of international concern (PHEIC) on 30th January 2020, and Ghana reported its first two confirmed cases on 12th March 2020.


2020 ◽  
pp. 109019812098067
Author(s):  
Wen-Ying Sylvia Chou ◽  
Anna Gaysynsky ◽  
Robin C. Vanderpool

Online misinformation regarding COVID-19 has undermined public health efforts to control the novel coronavirus. To date, public health organizations’ efforts to counter COVID-19 misinformation have focused on identifying and correcting false information on social media platforms. Citing extant literature in health communication and psychology, we argue that these fact-checking efforts are a necessary, but insufficient, response to health misinformation. First, research suggests that fact-checking has several important limitations and is rarely successful in fully undoing the effects of misinformation exposure. Second, there are many factors driving misinformation sharing and acceptance in the context of the COVID-19 pandemic—such as emotions, distrust, cognitive biases, racism, and xenophobia—and these factors both make individuals more vulnerable to certain types of misinformation and also make them impervious to future correction attempts. We conclude by outlining several additional measures, beyond fact-checking, that may help further mitigate the effects of misinformation in the current pandemic.


: The novel coronavirus (COVID-19) has effected the 213 countries around the world.It has declared a Public Health Emergency of International Concern on 30 January 2020 by WHO and created tremendous chaos around the world, affecting people’s lives and causing a large number of deaths. On the date of 21st April 2020 total covid confirmed cases are 5,090,977,recovered cases are 2,025,878 and death cases are 329,757. To study the relation between the confirmed ,recovered and death cases in India this study has been undertaken . For the same Ratio analysis technique is used. Here will trying to find that the number of recovered cases will have effect the number of death cases.


Author(s):  
Fahim Aslam

The current outbreak of the novel coronavirus also known as COVID-19 was declared as a public health emergency by the WHO where over a million people have been affected by the disease with over 50000 deaths till date. Social distancing is a method to minimize crowd interactions and prevent the spread of disease within groups of people. This is a common practice which has been carried out over generations to minimize the spread of virus by limiting its reproduction rate (R0) among communities. The article focuses on how social distancing has been used to deal previous pandemics globally and the issues that needs to be addressed to tackle the COVID-19 threat.


Author(s):  
Aswathy R Devan ◽  
Bhagyalakshmi Nair ◽  
Ayana R Kumar ◽  
Jaggaiah N Gorantla Gorantla ◽  
T. S. Aishwarya ◽  
...  

: Months after WHO declared COVID-19 as a Global Public Health Emergency of International Concern, it does not seem to be flattening the curve as we are still devoid of an effective vaccine and treatment modality. Amid such uncertainty, being immune is the best strategy to defend against corona attack. As the whole world is referring back to immune-boosting grandma remedies, interest is rekindled in the Indian system of Medicine, which is gifted with an abundance of herbal medicines as well as remedies. Among them, spices (root, rhizome, seed, fruit, leaf, bud, and flower of various plants used to add taste and flavors to food) are bestowed with immense medicinal potential. A plethora of clinical as well as preclinical studies reported the effectiveness of various spices for various ailments. The potential immune-boosting properties together with its excellent safety profile are making spices the current choice of Phyto-research as well as the immune-boosting home remedies during these sceptical times. The present review critically evaluates the immune impact of various Indian spices and their potential to tackle the novel coronavirus, with comments on the safety and toxicity aspects of spices.


Author(s):  
Kamla Pathak ◽  
Devender Pathak ◽  
Ramakant Yadav ◽  
Raj Kumar

Corona viruses are a large family of viruses that cause illness ranging from the common cold to more severe diseases. A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. On 30 January 2020, the WHO Director-General declared the novel corona virus (COVID-19) outbreak a public health emergency of international concern. Many fatalities have occurred and continue to happen. Despite staggering research efforts for therapeutics, complete cure is still a distant dream. The write up updates the treatment approaches utilized in clinical settings across the globe and the clinical trials registered in the Federal register and WHO register for drugs and vaccines to combat the pandemic.


Sign in / Sign up

Export Citation Format

Share Document